JOHN HOPE FRANKLIN CENTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
- Conditions
- Interventions
- First Posted Date
- 2008-02-12
- Last Posted Date
- 2014-07-09
- Lead Sponsor
- Duke University
- Target Recruit Count
- 67
- Registration Number
- NCT00613093
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2013-05-27
- Lead Sponsor
- Duke University
- Target Recruit Count
- 41
- Registration Number
- NCT00612339
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Duke University
- Target Recruit Count
- 59
- Registration Number
- NCT00612430
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Ph I SU011248 + Irinotecan in Treatment of Pts w MG
- Conditions
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2014-07-21
- Lead Sponsor
- Duke University
- Target Recruit Count
- 25
- Registration Number
- NCT00611728
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Duke University
- Target Recruit Count
- 15
- Registration Number
- NCT00610506
- Locations
- 🇺🇸
Dept Psychiatry, Duke University Medical Center, Durham, North Carolina, United States
Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 120
- Registration Number
- NCT00610610
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 60
- Registration Number
- NCT00610909
- Locations
- 🇺🇸
Department of Psychiatry Clinical Trial Team, Duke University, Durham, North Carolina, United States
Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2014-03-12
- Lead Sponsor
- Duke University
- Target Recruit Count
- 56
- Registration Number
- NCT00611325
- Locations
- 🇺🇸
Duke University Health System, Durham, North Carolina, United States
Diagnostic Yield of Vitreous Biopsy in Sarcoid Uveitis
- Conditions
- Interventions
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- Duke University
- Target Recruit Count
- 150
- Registration Number
- NCT00609687
- Locations
- 🇺🇸
Duke University Eye Center, Durham, North Carolina, United States
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
- Conditions
- Interventions
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Duke University
- Target Recruit Count
- 130
- Registration Number
- NCT00609505
- Locations
- 🇺🇸
Maria Parham Medical Center, Henderson, North Carolina, United States
🇺🇸Scotland Cancer Treatment Center, Laurinburg, North Carolina, United States
🇺🇸Gibson Cancer Center, Lumberton, North Carolina, United States